Frequency and predictors of no-reflow phenomenon in patients with COVID-19 presenting with ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

Frequency and predictors of no-reflow phenomenon in patients with COVID-19 presenting with ST-segment elevation myocardial infarction

Published:2021-05-31 Issue: Volume: Page:1-9
ISSN:0001-5385
Container-title:Acta Cardiologica
language:en
Short-container-title:Acta Cardiologica

Author:

Güler Arda¹^ORCID,Gürbak İsmail¹,Panç Cafer¹,Güner Ahmet¹^ORCID,Ertürk Mehmet¹

Affiliation:

1. Department of Cardiology, Health Sciences University, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2021.1931638

Reference29 articles.

1. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

2. Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care

3. The "no-reflow" phenomenon: basic science and clinical correlates

4. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction

5. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score;Circulation: Cardiovascular Interventions;2024-04

2. Post-myocardial Infarction Ventricular Septal Defect in the Setting of No-Reflow and COVID;Cureus;2023-07-07

3. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial;Acta Cardiologica;2023-05-12

4. Impact of D-dimer levels on no-reflow phenomenon following percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis;Acta Cardiologica;2022-07-05

5. Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention;Journal of Interventional Cardiology;2022-04-15